Treatment of Extraesophageal Reflux With the Reza Band UES Assist Device

Status Completed

Clinical Trial Summary

Clinical Trial Description

The purpose of the study is to determine the safety and effectiveness of non-invasive Reza Band UES Assist Device for the treatment of esophagopharyngeal reflux with extra-esophageal symptoms (chronic cough, choking, aspiration, chronic post nasal drip, globus, sore throat, throat clearing). Reza Band is to be worn when sleeping. The patient will put the Reza Band on at bedtime and take it off upon waking.

This is a prospective, non-randomized, open label, multicenter study designed to assess the safety and effectiveness of the Reza Band. At up to 5 investigational sites, up to 100 subjects will be enrolled.

The primary effectiveness endpoint is to be evaluated by the Reflux Symptom Index (RSI). Success is defined as >25% reduction in the RSI at the last follow-up, as compared to the baseline RSI. The RSI is a validated nine-item patient-administered outcome questionnaire designed to document symptoms and severity. Patients are asked to rate how nine problems have affected them on a scale of 0 (no problem) to 5 (severe problem), with a maximum total score of 45.

All adverse reactions being reported will be evaluated with the frequency and percent of subjects of each reaction being summarized by severity and by relationship to the Reza Band. Since some subjects may report the same event several times (e.g., redness), the first occurrence of the worst reported case of the event will be used for the purpose of analysis.

The incidence of site reactions, including laryngospasm, choking, pain, cough and hoarseness will be summarized. Exact 95% confidence intervals for the incidence rate of site reactions will be presented. ;

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Laryngopharyngeal Reflux

Clinical Trial Details

NCT number	NCT01857713
Study type	Interventional
Source	Somna Therapeutics, L.L.C.
Contact
Status	Completed
Phase	N/A
Start date	April 2013
Completion date	September 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06205446` - Application of Diaphragmatic Breathing in Patients With Disorders of Gut-brain Interaction	N/A
Completed	`NCT02552966` - Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin	N/A
Completed	`NCT01450748` - Efficacy and Safety of Alginos Oral Suspension to Treat Laryngopharyngeal Reflux	Phase 3
Recruiting	`NCT04827355` - Reflux Band in Laryngopharyngeal Reflux	N/A
Not yet recruiting	`NCT03455803` - Effect of CPAP Therapy on LPR Among Patients With OSAS	N/A
Withdrawn	`NCT02530879` - Comparison of Voice Therapy and Antireflex Therapy in LPR	Phase 4
Completed	`NCT01854970` - Benefit of Pharyngeal and Oesophageal pH-impedance of Patients With High Suspicion of Laryngopharyngeal Reflux	N/A
Completed	`NCT00321503` - Study of an Oropharyngeal Aerosolized pH Probe for Diagnosing Laryngopharyngeal Reflux (LPR)	N/A
Terminated	`NCT01317472` - The Effects of Dexlansoprazole for the Treatment of Throat-Related Reflux	N/A
Completed	`NCT01880892` - Laryngopharyngeal Reflux Before and After Cricopharyngeal Myotomy	N/A
Completed	`NCT02183961` - Three Methods Used in the Diagnosis of EER in Children With OME	N/A
Not yet recruiting	`NCT01328652` - Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy	Phase 4
Not yet recruiting	`NCT04383262` - Lexiva for the Treatment of LPR	Phase 3
Recruiting	`NCT04984304` - Individualized Diagnosis and Treatment of Extraesophageal Reflux in Patients With Chronic Cough	N/A
Withdrawn	`NCT03463395` - Efficacy of Reza Band for the Treatment of Laryngopharyngeal Reflux	N/A
Completed	`NCT00864396` - Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux	Phase 1
Completed	`NCT03619811` - Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease	N/A
Recruiting	`NCT05879029` - Clinical Study of Jinsang Liyan Capsules Combined With PPI in the Treatment of LPRD	Phase 4
Recruiting	`NCT05204303` - LPR Fluorescence Pilot
Terminated	`NCT01777854` - Anti-reflux Control to Decrease Post Tonsillectomy Pain	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.